Navigation Links
VisualSonics Appoints New President and CEO
Date:11/3/2009

TORONTO, Nov. 3 /PRNewswire/ - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro imaging systems, today announced that the Board of Directors has permanently appointed Anil Amlani, as President and Chief Executive Officer of the Company. Mr. Amlani, previously the Chief Financial Officer, has served as interim President and Chief Executive Office since May 2009.

"VisualSonics has aggressive growth plans to expand our base small animal business into human applications with our micro-ultrasound platform. The rollout of these new products and expansion of our small animal business requires experienced management," said Jeff Courtney, Chairman of VisualSonics, Inc. "Anil's expertise in the management of a diversified healthcare business supports our long term vision for VisualSonics as the world leader in the micro-imaging market."

Mr. Amlani, who joined VisualSonics in 2005, was previously responsible for the strategic direction of the Company by overseeing its short- and long-term operations and implementing corporate development, financial management and long-term business plans. Prior to joining VisualSonics, Mr. Amlani was Chief Operating Officer and Chief Financial Officer at MDS Proteomics and Senior Vice President and Chief Financial Officer at Cancom, where he successfully managed financings raising in excess of $600 million. He previously held senior positions at TD Bank including Head of Finance, Commercial and Retail Banking; and with AT&T Canada as Senior Vice President of Wholesale division and Strategic Planning and New Business Development. Mr. Amlani obtained his Chartered Accountancy designation in London, England and Canada.

    About VisualSonics
    ------------------

VisualSonics is the world leader in real time, in vivo, high-resolution micro imaging systems designed specifically for preclinical research. The Company's cutting edge technologies allow researchers at the world's most prestigious pharmaceutical and biotechnology companies, hospitals and universities to conduct research in cardiovascular, cancer, neurobiology and developmental biology areas. The micro imaging technologies support research applications that include genetic research, phenotypic studies and drug development. VisualSonics micro imaging platforms combine high-resolution, real time in vivo imaging at reasonable cost with ease-of-use and quantifiable results.

SOURCE VisualSonics Inc.


'/>"/>
SOURCE VisualSonics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer
2. HealthCare Alliance Group LLC Appoints New Director of Business Development
3. HealthWell Foundation(R) Appoints New Executive Director
4. LifeCare Hospitals Appoints New Executive Vice President of Operations
5. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
6. Heartland Information Services Appoints New Chief Executive Officer
7. AMT Appoints New Chief Executive Officer
8. Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer
9. The Childrens Center of Wayne County Appoints Ballantyne as Chief Development Officer
10. GENova appoints Dr. Wang Chong to Scientific Advisory Board
11. InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch to ... - living - adjustment (COLA) is a bad deal for older and disabled Americans, ... index (CPI) would grow even more slowly than the conventional one that is currently ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health care ... unit of Constellation Inc., a move that will help the company better serve its ... Louis, the acquisition is expected to help MTS expand its presence in ...
(Date:7/20/2017)... ... ... “Fidget”: a fun-filled, action-packed memoir of adventures. “Fidget” is the creation of ... who was a summa cum laude graduate of Gardner Webb University. She has won ... her retirement from public school, Lynn continued to pursue her love for music through ...
(Date:7/18/2017)... ... 2017 , ... The results of an international clinical trial, led in part by a UC ... of muscular dystrophy holds promise for a subgroup of patients. , In a paper just ... at 53 study sites in 18 countries describe the clinical benefit of using the drug ...
(Date:7/18/2017)... ... July 19, 2017 , ... ... it’s Corporate Social Responsibility Initiative in the prestigious CEO World Awards®. The ... organizational performance, new products and services, CEO case studies, corporate social responsibility, and ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
Breaking Medicine Technology: